vs

Side-by-side financial comparison of PagerDuty, Inc. (PD) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $124.5M, roughly 1.1× PagerDuty, Inc.). PagerDuty, Inc. runs the higher net margin — 129.7% vs -5.3%, a 135.0% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 4.7%). PagerDuty, Inc. produced more free cash flow last quarter ($24.1M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 5.9%).

PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

PD vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.1× larger
TOI
$142.0M
$124.5M
PD
Growing faster (revenue YoY)
TOI
TOI
+36.9% gap
TOI
41.6%
4.7%
PD
Higher net margin
PD
PD
135.0% more per $
PD
129.7%
-5.3%
TOI
More free cash flow
PD
PD
$21.9M more FCF
PD
$24.1M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
5.9%
PD

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PD
PD
TOI
TOI
Revenue
$124.5M
$142.0M
Net Profit
$161.6M
$-7.5M
Gross Margin
85.3%
Operating Margin
6.5%
-4.9%
Net Margin
129.7%
-5.3%
Revenue YoY
4.7%
41.6%
Net Profit YoY
2827.7%
43.0%
EPS (diluted)
$1.69
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PD
PD
TOI
TOI
Q4 25
$124.5M
$142.0M
Q3 25
$123.4M
$136.6M
Q2 25
$119.8M
$119.8M
Q1 25
$121.4M
$104.4M
Q4 24
$118.9M
$100.3M
Q3 24
$115.9M
$99.9M
Q2 24
$111.2M
$98.6M
Q1 24
$111.1M
$94.7M
Net Profit
PD
PD
TOI
TOI
Q4 25
$161.6M
$-7.5M
Q3 25
$9.6M
$-16.5M
Q2 25
$-7.2M
$-17.0M
Q1 25
$-8.8M
$-19.6M
Q4 24
$-5.9M
$-13.2M
Q3 24
$-10.9M
$-16.1M
Q2 24
$-17.1M
$-15.5M
Q1 24
$-28.2M
$-19.9M
Gross Margin
PD
PD
TOI
TOI
Q4 25
85.3%
Q3 25
84.6%
Q2 25
84.0%
Q1 25
83.6%
Q4 24
83.0%
Q3 24
82.7%
Q2 24
82.6%
Q1 24
81.7%
Operating Margin
PD
PD
TOI
TOI
Q4 25
6.5%
-4.9%
Q3 25
2.9%
-5.9%
Q2 25
-8.6%
-9.4%
Q1 25
-9.6%
-9.5%
Q4 24
-8.7%
-11.9%
Q3 24
-13.8%
-13.9%
Q2 24
-19.5%
-16.6%
Q1 24
-30.1%
-19.0%
Net Margin
PD
PD
TOI
TOI
Q4 25
129.7%
-5.3%
Q3 25
7.8%
-12.1%
Q2 25
-6.0%
-14.2%
Q1 25
-7.2%
-18.8%
Q4 24
-5.0%
-13.1%
Q3 24
-9.4%
-16.1%
Q2 24
-15.4%
-15.7%
Q1 24
-25.3%
-21.0%
EPS (diluted)
PD
PD
TOI
TOI
Q4 25
$1.69
$-0.04
Q3 25
$0.10
$-0.14
Q2 25
$-0.07
$-0.15
Q1 25
$-0.12
$-0.21
Q4 24
$-0.07
$-0.14
Q3 24
$-0.14
$-0.18
Q2 24
$-0.26
$-0.17
Q1 24
$-0.34
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PD
PD
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$547.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$320.5M
$-15.7M
Total Assets
$1.0B
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PD
PD
TOI
TOI
Q4 25
$547.8M
Q3 25
$567.9M
Q2 25
$597.1M
Q1 25
$570.8M
Q4 24
$542.2M
Q3 24
$599.3M
Q2 24
$592.8M
$9.9M
Q1 24
$571.2M
$29.8M
Total Debt
PD
PD
TOI
TOI
Q4 25
Q3 25
Q2 25
Q1 25
$484.5M
Q4 24
Q3 24
Q2 24
Q1 24
$489.5M
Stockholders' Equity
PD
PD
TOI
TOI
Q4 25
$320.5M
$-15.7M
Q3 25
$180.7M
$-12.3M
Q2 25
$145.7M
$-9.0M
Q1 25
$129.8M
$5.1M
Q4 24
$111.6M
$3.6M
Q3 24
$164.7M
$15.5M
Q2 24
$174.0M
$29.2M
Q1 24
$171.6M
$41.3M
Total Assets
PD
PD
TOI
TOI
Q4 25
$1.0B
$164.7M
Q3 25
$891.5M
$163.6M
Q2 25
$926.8M
$159.8M
Q1 25
$927.3M
$164.0M
Q4 24
$866.8M
$172.7M
Q3 24
$916.0M
$179.2M
Q2 24
$924.0M
$179.6M
Q1 24
$925.3M
$204.5M
Debt / Equity
PD
PD
TOI
TOI
Q4 25
Q3 25
Q2 25
Q1 25
3.73×
Q4 24
Q3 24
Q2 24
Q1 24
2.85×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PD
PD
TOI
TOI
Operating Cash FlowLast quarter
$24.8M
$3.2M
Free Cash FlowOCF − Capex
$24.1M
$2.2M
FCF MarginFCF / Revenue
19.3%
1.5%
Capex IntensityCapex / Revenue
0.6%
0.7%
Cash ConversionOCF / Net Profit
0.15×
TTM Free Cash FlowTrailing 4 quarters
$117.6M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PD
PD
TOI
TOI
Q4 25
$24.8M
$3.2M
Q3 25
$34.0M
$-12.6M
Q2 25
$30.7M
$-10.2M
Q1 25
$31.4M
$-5.0M
Q4 24
$22.1M
$4.2M
Q3 24
$35.8M
$819.0K
Q2 24
$28.6M
$-15.7M
Q1 24
$22.2M
$-15.9M
Free Cash Flow
PD
PD
TOI
TOI
Q4 25
$24.1M
$2.2M
Q3 25
$33.1M
$-13.2M
Q2 25
$30.2M
$-11.4M
Q1 25
$30.3M
$-5.3M
Q4 24
$21.5M
$2.4M
Q3 24
$35.1M
$417.0K
Q2 24
$28.2M
$-17.5M
Q1 24
$21.2M
$-16.5M
FCF Margin
PD
PD
TOI
TOI
Q4 25
19.3%
1.5%
Q3 25
26.8%
-9.7%
Q2 25
25.2%
-9.5%
Q1 25
24.9%
-5.1%
Q4 24
18.1%
2.4%
Q3 24
30.3%
0.4%
Q2 24
25.4%
-17.7%
Q1 24
19.1%
-17.4%
Capex Intensity
PD
PD
TOI
TOI
Q4 25
0.6%
0.7%
Q3 25
0.7%
0.4%
Q2 25
0.4%
1.0%
Q1 25
0.9%
0.3%
Q4 24
0.5%
1.8%
Q3 24
0.5%
0.4%
Q2 24
0.4%
1.9%
Q1 24
0.9%
0.6%
Cash Conversion
PD
PD
TOI
TOI
Q4 25
0.15×
Q3 25
3.55×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PD
PD

US$88.8M71%
Non Us$35.7M29%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons